Clinical Deep Dives

ตอน

• 
  PSYCH 095: Genetics of Schizophrenia 18.08.2026 47นาที

  Medlock Holmes enters perhaps the most intricate room in the entire Psychiatric Archive.Above the doorway is engraved:“The Library of Inheritance.”Thousands of leather-bound books stretch from floor to ceiling.Each volume represents a human genome.Holmes expects to find a single book labelled The Schizophrenia Gene.Instead, he finds nothing of the sort.The librarian smiles.“You are looking for one culprit.”“There are hundreds.”“And none acts alone.”Holmes immediately understands.Schizophrenia is not caused by one defective gene.It is the consequence of many genetic variations interacting with one another, with brain development, and with the environment.He walks into the Hall of Families.Portraits cover the walls.Some families have no illness.Others contain several generations affected by schizophrenia.One large family tree glows brighter with every affected relative.The pattern is unmistakable.The closer one’s biological relationship to an affected individual, the greater the risk.The general population carries approximately a 1% lifetime risk.A sibling carries roughly a 10% risk.A child of one affected parent has around a 13% risk.When both parents have schizophrenia, risk rises dramatically-approaching 45–46%. Holmes realises that genes clearly matter, but they are not destiny.The next chamber contains identical mirrors.Each pair reflects identical twins.Holmes notices something fascinating.When one monozygotic twin develops schizophrenia, the other does not always.The concordance is only around 50%.If genes were the entire story, concordance would be 100%.Instead, twin studies estimate schizophrenia heritability at approximately 80%, leaving an important role for environmental and developmental influences.Across the corridor lies the House of Adoption.Children leave one family and grow up in another.Despite completely different homes, children born to parents with schizophrenia continue to carry increased risk.The illness follows biological inheritance more strongly than upbringing alone.Adoption studies therefore provide some of the strongest evidence that schizophrenia has a substantial genetic basis independent of the shared family environment.Holmes now reaches the most modern room of the archive.Rows of computers illuminate billions of DNA letters.This is the Genome Observatory.Scientists no longer search one gene at a time.Instead, they compare millions of genetic variants across tens of thousands of individuals.This approach is known as the Genome-Wide Association Study (GWAS).Rather than discovering a single mutation, GWAS has identified hundreds of genetic loci that each contribute only a tiny increase in risk.Most variants individually alter risk by only a few percent.Their power comes from acting together.A gigantic city skyline appears.Every building represents a different gene.Holmes notices that the tallest towers belong to genes involved in:* synapse formation* glutamate signalling* calcium channels* neuronal development* synaptic plasticityOne tower bears the familiar name DRD2-the dopamine D₂ receptor.Nearby stand GRIN2A, GRM3, CACNA1C, CACNB2, and many others.Holmes smiles.The genetics are pointing toward the same biological pathways long suspected from neuroscience:not one abnormal chemical-but abnormalities in how neurons connect, communicate, and remodel themselves.The next gallery is darker.Here Holmes finds damaged pages missing from books.Entire chapters have disappeared.These are Copy Number Variants (CNVs).Unlike tiny spelling mistakes, CNVs involve deletions or duplications of large stretches of DNA.Although rare, they can have powerful effects.The most famous example is the 22q11.2 deletion, where carriers have up to a 30% risk of schizophrenia or another psychotic disorder.Other important CNVs affect genes such as NRXN1, which plays a key role in synapse formation.Holmes realises that rare variants carry much larger individual risks than common genetic variants.Further inside, Holmes enters the Sequencing Chamber.Scientists now read every coding region of the genome.Rare mutations emerge.Among them is SETD1A, one of the strongest single-gene risk factors yet discovered.Other rare variants involve genes regulating:* NMDA receptors* AMPA receptors* neuronal migration* transcription* ion channelsAlthough individually uncommon, together they reinforce one central message:the biology repeatedly converges upon brain development and synaptic function.Holmes reaches an immense mosaic.Each tile is tiny.Individually insignificant.Together they create an entire portrait.A brass plaque reads:Polygenic Risk ScoreRather than asking whether someone possesses one schizophrenia gene, researchers calculate the combined effect of thousands of common variants.Current polygenic scores explain only a modest proportion of overall risk and cannot yet diagnose schizophrenia, but they increasingly help researchers understand biological vulnerability and may one day assist in identifying high-risk populations or tailoring treatments.Another surprise awaits.The final gallery contains books labelled:* Bipolar Disorder* Autism Spectrum Disorder* ADHD* Intellectual Disability* Major DepressionHolmes expects separate libraries.Instead, bridges connect every shelf.Many genetic variants are shared across these disorders.The boundaries between diagnoses become less rigid than once imagined.Schizophrenia is increasingly viewed as part of a broader neurodevelopmental spectrum, with overlapping biology rather than isolated diseases.At the end of the archive Holmes discovers one final inscription.“Genes load the gun.”“Development shapes the weapon.”“Environment decides whether it is ever fired.”Holmes closes the final book.Schizophrenia is profoundly genetic.But genes do not write destiny.They write probability.The final story is written through the lifelong conversation between biology and experience.Key Takeaways* Schizophrenia is one of the most heritable psychiatric disorders, with heritability estimated at approximately 80–81%.* Risk increases with biological relatedness to an affected family member.* Lifetime risk is approximately 1% in the general population, ~10% for siblings, ~13% for children of one affected parent, and ~46% when both parents are affected.* Monozygotic twins show much higher concordance than dizygotic twins, but concordance is well below 100%, demonstrating an important environmental contribution.* Adoption studies confirm that familial transmission is largely genetic rather than purely environmental.* Genome-wide association studies (GWAS) have identified hundreds of common genetic loci associated with schizophrenia.* Individual common variants have very small effects, but collectively contribute substantially to genetic liability.* Important implicated genes include DRD2, GRIN2A, GRM3, CACNA1C, CACNB2, and many genes involved in synaptic biology.* Rare copy number variants (CNVs), particularly 22q11.2 deletion and NRXN1 deletions, confer much larger individual risks.* Rare coding variants identified through sequencing studies include SETD1A and genes regulating glutamatergic signalling and neuronal development.* Polygenic risk scores combine thousands of common variants but currently explain only a limited proportion of disease risk and are not yet clinically diagnostic.* Genetic risk overlaps extensively with bipolar disorder, autism spectrum disorder, ADHD, intellectual disability, and major depression.* Current evidence supports schizophrenia as part of a broader neurodevelopmental spectrum rather than a genetically isolated disorder.* Multiple genetic approaches converge on abnormalities of synaptic plasticity, neuronal connectivity, glutamatergic transmission, calcium signalling, and brain development.* Genes increase susceptibility but do not determine outcome; environmental and developmental factors remain essential in disease expression. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe
• 
  PSYCH 094: Global Burden of Schizophrenia 17.08.2026 41นาที

  Medlock Holmes arrives at the Hall of Human Burden.Unlike previous investigations, this hall contains no microscopes, MRI scanners, or genetic maps.Instead, the walls are covered with clocks.Some clocks have stopped too early.Others continue to tick, but their hands barely move, representing lives lived with profound disability rather than early death.Holmes quickly realises that measuring illness is not simply about counting deaths.Many illnesses kill.Others steal decades of healthy living.Schizophrenia belongs overwhelmingly to the second group.At the centre of the hall stands an enormous balance labelled DALY - Disability-Adjusted Life Years.One side is engraved Years of Life Lost (YLL).The other reads Years Lived with Disability (YLD).Together they reveal the true cost of disease-not merely how long people live, but how well they live. Schizophrenia contributes relatively less through mortality than through prolonged disability, making it one of the world’s leading causes of disability among young adults.Holmes walks through a giant world map.Every continent glows.No country is dark.The lesson is immediate.There is no human society free from schizophrenia.Whether in highly industrialised cities, isolated villages, or traditional rural communities, schizophrenia appears wherever human beings live. Although prevalence varies modestly between regions, remarkably similar syndromes emerge across cultures. Voices comment. Thoughts seem controlled. Delusions develop. Negative symptoms erode motivation and social engagement. The illness speaks different cultural languages but follows recognisable biological patterns.He pauses beside an older collection of maps.Some early psychiatrists once believed schizophrenia was largely a Western disease.Modern epidemiology overturned that assumption.Large international studies, particularly those coordinated by the World Health Organization, demonstrated that schizophrenia occurs globally and can be recognised reliably using standardised diagnostic criteria.Holmes now enters the Hall of Numbers.Worldwide, lifetime prevalence remains close to 0.7%, or roughly 7 people per 1,000, while annual incidence is approximately 0.2–0.3 new cases per 1,000 population. These figures vary somewhat between countries, but far less dramatically than many other chronic diseases.Yet another room tells a more unsettling story.Although schizophrenia affects a relatively small proportion of the population, those affected lose many years of healthy life.People with schizophrenia die, on average, 14–20 years earlier than the general population.Contrary to popular belief, suicide is not the largest contributor to premature mortality.Cardiovascular disease now accounts for the greatest share of excess deaths, driven by smoking, obesity, diabetes, sedentary lifestyles, metabolic effects of antipsychotic medication, and unequal access to physical healthcare. Suicide remains tragically common, particularly during the early years of illness and around hospital discharge, but heart disease has become the dominant killer.Nearby, Holmes discovers a corridor labelled Migration.The walls display families who crossed borders seeking opportunity.Unexpectedly, schizophrenia becomes more common-not because migration changes genes, but because migration often changes environments.First- and second-generation migrants frequently experience higher rates of schizophrenia than host populations, especially when social exclusion, discrimination, isolation, and loss of community support accompany migration. The illness appears to emerge from an interaction between biological vulnerability and social adversity.The next chamber examines Culture and Recovery.Here Holmes encounters one of psychiatry’s most intriguing mysteries.Across several WHO studies, people living in many developing countries often experienced longer periods of remission and better functional recovery than comparable patients in wealthier nations.The explanation remains uncertain.Possible contributors include stronger family structures, lower expressed emotion, greater community integration, different social expectations, and reduced social isolation. Recovery appears influenced not only by biology but also by the environment into which recovery occurs.Holmes then enters the Hall of Comorbidity.Every door opens onto another illness.Cardiovascular disease.Diabetes.Obesity.Substance misuse.HIV.Hepatitis.COVID-19.None exist independently.Substance use-particularly cannabis-further complicates the picture. Heavy cannabis use increases the risk of psychotic disorders, especially among genetically vulnerable individuals and those exposed during adolescence. Alcohol, stimulants, nicotine, and opioids frequently coexist with schizophrenia, worsening relapse rates, treatment adherence, homelessness, and mortality.Near the exit, Holmes finds perhaps the most hopeful exhibit.A clock labelled Duration of Untreated Psychosis.Its hands move rapidly.The longer psychosis remains untreated, the poorer the long-term outcome tends to be.Early intervention services, coordinated specialty care, family education, vocational support, and rapid access to treatment consistently improve quality of life, reduce disability, and shorten untreated psychosis. Prevention, Holmes concludes, begins long before chronic disability develops.As Holmes leaves the Hall of Human Burden, he looks back one final time.Schizophrenia is uncommon.But its impact is enormous.Not because it affects the greatest number of people--but because it touches nearly every dimension of life:health,family,education,employment,identity,community,and hope.The greatest burden of schizophrenia is not measured by counting patients.It is measured by counting lives interrupted.Key Takeaways* Schizophrenia contributes disproportionately to global disability despite relatively low prevalence.* Disease burden is measured using DALYs, combining years of life lost (YLL) and years lived with disability (YLD).* Lifetime prevalence is approximately 7 per 1,000 people worldwide.* Annual incidence is approximately 0.2–0.3 per 1,000 people.* Schizophrenia occurs in every culture studied and has no known schizophrenia-free population.* Clinical presentation is remarkably similar across cultures despite differences in beliefs and social practices.* WHO international studies demonstrated comparable incidence but important differences in recovery patterns across countries.* Many developing countries have demonstrated longer remissions and better long-term outcomes than wealthier nations.* Family support, community integration, and lower expressed emotion may contribute to improved recovery.* People with schizophrenia lose approximately 14–20 years of life expectancy.* Cardiovascular disease is now the leading cause of premature mortality.* Suicide risk remains markedly elevated, particularly early after onset and following hospital discharge.* Substance use disorders are common and worsen prognosis, especially cannabis use disorder.* Migration, discrimination, and social marginalisation increase schizophrenia risk beyond genetic vulnerability alone.* Early intervention and reducing the duration of untreated psychosis improve long-term outcomes.* Schizophrenia imposes enormous direct healthcare costs and even greater indirect costs through disability and lost productivity.* Most of the global burden arises from long-term disability rather than mortality alone. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe
• 
  PSYCH 093: Phenomenology of Schizophrenia 16.08.2026 1ชม. 1นาที

  Medlock Holmes enters an enormous archive filled with thousands of witness statements.Some describe voices no one else can hear.Others speak of thoughts being inserted, removed, or broadcast beyond the boundaries of the mind.Some accounts are crowded with elaborate conspiracies. Others contain only a few sparse words, long silences, diminished expression, and a life gradually emptied of purpose.Every file is different.Yet all have been placed beneath the same heading:Schizophrenia.Holmes immediately recognises the central challenge. There is no definitive laboratory test that confirms the diagnosis. No single hallucination, delusion, movement, or pattern of speech belongs exclusively to schizophrenia. The disorder remains defined through phenomenology: the disciplined study of what a person experiences, how those experiences are expressed, and how they change across time.The investigation begins with history. Kraepelin organised the illness around course and deterioration, describing dementia praecox as a disruption of intellect, emotion, and volition. Bleuler shifted attention towards the fragmentation of psychological functions and his Four As: disturbed associations, autism, abnormal affect, and ambivalence. Schneider later attempted to improve diagnostic reliability through first-rank symptoms such as thought insertion, thought withdrawal, thought broadcasting, passivity experiences, and voices commenting or conversing.Each investigator illuminated part of the landscape.None captured the whole country.Modern diagnostic systems therefore rely not upon one pathognomonic clue, but upon patterns of symptoms, duration, functional change, and exclusions. Hallucinations, delusions, disorganised speech, abnormal behaviour, and negative symptoms must be interpreted alongside mood episodes, substance exposure, medical illness, developmental history, and longitudinal course.Holmes then divides the archive into several great chambers.The first contains psychotic symptoms. Hallucinations may arise in any sensory modality, although auditory voices are most common. Delusions range from persecution and reference to grandiosity, passivity, religious meaning, and altered ownership of thought. Yet neither hallucinations nor delusions are unique to schizophrenia. Their diagnostic significance lies in their severity, persistence, context, and relationship with the rest of the syndrome.The second chamber contains negative symptoms.Here the clues are quieter and more easily missed: avolition, anhedonia, asociality, diminished emotional expression, and alogia. These symptoms often predict disability more powerfully than hallucinations or delusions. Holmes also learns to distinguish primary negative symptoms from those caused by depression, medication, institutional deprivation, fear, or distracting psychosis. What appears to be absence of motivation may have several entirely different causes.The third chamber contains disorganisation.Speech becomes tangential, vague, derailed, or incoherent. Behaviour loses its internal structure. Gestures become purposeless, clothing inappropriate, affect incongruent, and ordinary action strangely fragmented. Thought disorder is not a disorder of what someone believes, but of how ideas are linked and communicated.Around these principal chambers lie others that psychiatry has sometimes neglected: depression, anxiety, trauma, obsessive-compulsive symptoms, agitation, hostility, suicidality, impaired insight, and cognitive difficulty. These are not decorative details. They shape risk, distress, engagement, functioning, and treatment.Holmes realises that phenomenology requires more than checking boxes.A voice may be threatening, comforting, commanding, or companionable. A delusion may be fleeting or systematised, terrifying or grandiose. Silence may reflect alogia, depression, fear, sedation, or distrust. The same outward sign may conceal entirely different inner experiences.The skilled clinician must therefore listen beyond the label.By the end of the investigation, Holmes understands that schizophrenia is not a single portrait but a gallery of shifting constellations. Its symptoms cluster into recognisable dimensions, yet each person’s pattern remains unique.The diagnosis begins with observation.Understanding begins with curiosity.Key Takeaways* Schizophrenia remains a phenomenologically defined disorder without a diagnostic biomarker.* Diagnosis depends upon symptom patterns, duration, functional change, longitudinal course, and exclusion of alternative causes.* Kraepelin emphasised course and deterioration; Bleuler focused on fragmentation of psychic functions; Schneider described first-rank symptoms.* No hallucination, delusion, or other single symptom is pathognomonic of schizophrenia.* DSM-5-TR requires at least two core symptoms, with at least one being delusions, hallucinations, or disorganised speech.* DSM-5-TR requires six months of disturbance, including at least one month of active symptoms.* Traditional subtypes of schizophrenia were removed because they lacked stability and predictive value.* Psychotic symptoms include hallucinations and delusions; they should not be used as a synonym for all positive symptoms.* Auditory hallucinations are most common, but multimodal hallucinations occur frequently.* Delusions differ in content, conviction, preoccupation, distress, and behavioural impact.* Negative symptoms include avolition, anhedonia, asociality, diminished emotional expression, and alogia.* Negative symptoms are major predictors of disability and long-term functioning.* Secondary negative symptoms may result from depression, psychosis, medication, environmental deprivation, or extrapyramidal effects.* Disorganisation includes formal thought disorder, inappropriate affect, abnormal behaviour, and some motor phenomena.* Depression, anxiety, trauma, obsessive-compulsive symptoms, agitation, substance use, and cognitive impairment commonly complicate schizophrenia.* Suicide risk is particularly elevated early in illness, during relapse, around admission or discharge, and when depression or emerging insight is present.* Violence risk should never be inferred from diagnosis alone; substance use, victimisation, threat beliefs, impulsivity, non-adherence, and previous behaviour matter more.* Insight is multidimensional and may vary across awareness of illness, symptoms, treatment need, and consequences.* Rating scales support consistency, but they must never replace the patient’s narrative.* Good phenomenology asks not only whether a symptom exists, but what it means within that person’s life. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe
• 
  PSYCH 092: Schizophrenia 15.08.2026 46นาที

  Schizophrenia is one of the most misunderstood disorders in medicine. It is not simply a condition of hallucinations and delusions; it is a disorder that disrupts perception, cognition, motivation, emotion, and the ability to connect with the world. For centuries it was viewed as madness, then as degeneration, later as a dopamine disorder, and now increasingly as a disorder of brain circuits, neurodevelopment, and dysfunctional neural networks.In this opening chapter of the schizophrenia series, Medlock Holmes begins the investigation by asking a deceptively simple question:What actually goes wrong inside a brain that loses its grip on reality?We explore the historical evolution of schizophrenia-from ancient descriptions of prophets and visionaries to modern neuroscience-and examine why the illness remains one of psychiatry’s greatest scientific challenges. The episode introduces psychosis not as a single disease but as a complex symptom that may arise from multiple underlying biological mechanisms.The chapter also explains why modern psychiatry is gradually moving beyond rigid diagnostic labels towards studying dimensions of dysfunction such as psychosis, cognition, negative symptoms, and affective disturbance. Rather than one illness with one cause, schizophrenia may represent several overlapping diseases sharing common clinical features.Finally, we examine why medication alone is never enough. The strongest evidence now shows that early comprehensive intervention-including psychological therapies, cognitive remediation, family education, community support, and pharmacological treatment-offers the greatest opportunity for long-term recovery.This episode serves as the gateway to the entire schizophrenia section, introducing the detective framework that will guide the chapters ahead as we investigate genetics, neurodevelopment, imaging, cognition, treatment, recovery, and the biology of psychosis itself.Key Takeaways• Schizophrenia is far more than hallucinations.It affects multiple domains including perception, cognition, motivation, emotion, social functioning, and independent living.• Psychosis remains one of neuroscience’s greatest mysteries.Understanding the neural mechanisms of psychosis is central to discovering better treatments and biologically based disease classifications.• Dopamine explains treatment-but probably not the whole disease.Current antipsychotics reduce dopamine signalling effectively, yet schizophrenia likely involves multiple interacting neural circuits extending well beyond dopamine.• Modern research is shifting from diagnoses to dimensions.Instead of asking “What diagnosis does this patient have?”, researchers increasingly ask which domains-psychosis, cognition, negative symptoms or mood dysfunction-are disrupted.• Schizophrenia is biologically heterogeneous.Patients sharing the same diagnosis may have very different underlying disease mechanisms.• Basic neuroscience is essential.Understanding memory, synaptic plasticity, neural circuitry and cortical communication is increasingly necessary for understanding schizophrenia.• Comprehensive care outperforms medication alone.The best outcomes occur when antipsychotic medication is combined with psychological therapy, cognitive remediation, family intervention, behavioural treatment, and community support.• Early intervention changes trajectories.The RAISE model demonstrates that coordinated early treatment during first-episode psychosis significantly improves long-term outcomes.• The future lies in personalised psychiatry.As biological mechanisms become clearer, schizophrenia may eventually be subdivided into distinct brain diseases with targeted treatments rather than one broad syndrome. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe
• 
  PSYCH 091: Anabolic-Androgenic Steroid-Related Disorders 14.08.2026 50นาที

  A famous bodybuilder walks into Medlock Holmes’ consulting room.He is physically magnificent.Broad shoulders. Sculpted chest. Powerful arms.Yet Holmes notices something else.The man cannot stop looking at his reflection.Every polished surface becomes another mirror.Every missed gym session feels catastrophic.Every slight reduction in muscle size feels like losing part of himself.Holmes quickly realises that this is not simply a story about muscles.It is a story about identity.Most people think anabolic-androgenic steroids (AAS) are drugs used by elite athletes chasing Olympic medals.Holmes discovers the opposite.Today, most users are ordinary men seeking a more muscular appearance rather than sporting success. The average age of first use is approximately 23 years, much later than most other illicit substances, and use is overwhelmingly confined to males.Holmes begins by separating two commonly confused substances.The drugs used by bodybuilders are anabolic-androgenic steroids, synthetic derivatives of testosterone designed to increase muscle growth while also producing masculinising effects.These are entirely different from corticosteroids such as prednisolone, which reduce inflammation and have virtually no muscle-building properties. Confusing these two families of steroids remains remarkably common among both patients and clinicians.The detective then asks a more interesting question.If testosterone is a natural hormone, why does it become dangerous?The answer lies in dosage.Medical testosterone replacement simply restores normal physiological levels.Illicit users often consume 10 to 100 times therapeutic doses, frequently combining several different steroids simultaneously (”stacking”) to achieve enormous supraphysiological androgen concentrations.The result is extraordinary muscle growth.But Holmes knows that biology never grants gifts without demanding payment.As the investigation progresses, Holmes uncovers a fascinating paradox.The body becomes stronger.The brain becomes less stable.Most users experience little psychiatric disturbance.However, a vulnerable minority develop profound psychological changes.Some become unusually energetic.Need less sleep.Feel invincible.Become impulsive.Spend recklessly.Display intense irritability.Others develop frank mania or even psychosis with grandiose or paranoid delusions. The risk increases substantially with higher steroid doses, particularly above the equivalent of 1,000 mg of testosterone per week.Then comes the opposite problem.When the steroids stop, testosterone production collapses.The hypothalamic-pituitary-testicular (HPT) axis has been suppressed by months of external hormones.Instead of euphoria comes exhaustion.Instead of confidence comes depression.Instead of libido comes sexual dysfunction.Some men become severely depressed during withdrawal, and a minority require antidepressants-or even electroconvulsive therapy-for prolonged episodes.Holmes soon encounters the most surprising diagnosis of all.Muscle dysmorphia.Unlike anorexia nervosa, where individuals see themselves as larger than they are, these men see themselves as too small, even when objectively extremely muscular.Every mirror lies.Every comparison hurts.Every kilogram of lost muscle feels like personal failure.This distorted body image becomes one of the strongest drivers of continued steroid use.Holmes realises the steroids are no longer building muscle.They are medicating fear.The detective next investigates dependence.Unlike cocaine or heroin, anabolic steroids produce relatively little acute intoxication.Yet dependence still develops.The textbook describes three interacting pathways.First, body-image anxiety drives repeated use because individuals fear losing muscularity.Second, endocrine withdrawal causes hypogonadism, depression, fatigue, reduced libido, and erectile dysfunction, encouraging users to restart steroids simply to feel normal again.Third, steroids themselves possess rewarding properties through actions involving dopamine, GABA, and opioid systems, producing feelings of confidence, power, and occasionally euphoria.Dependence therefore becomes far more complex than simple drug reward.It is simultaneously psychological, hormonal, and neurobiological.Holmes then turns his attention to the body.The muscles tell only half the story.Years of steroid exposure may produce:* Dilated cardiomyopathy* Accelerated coronary artery disease* Hypertension* Dyslipidaemia (↑ LDL, ↓ HDL)* Polycythaemia* Persistent hypogonadism* Infertility* Tendon rupture* Liver injury (particularly with oral 17-α-alkylated steroids)* Possible cognitive impairment associated with long-term exposureIronically, muscles often become stronger than the tendons attached to them.Holmes notes that some tendon ruptures occur not during heavy lifting-but during ordinary daily activities.Finally, Holmes asks the question that truly matters.How do you treat someone whose identity has become chemically reinforced?The answer is not simply to stop the steroids.Recovery requires rebuilding three different systems.The distorted body image requires cognitive behavioural therapy and sometimes serotonergic antidepressants.The suppressed endocrine system often requires careful management by an endocrinologist using physiological testosterone replacement, clomiphene, human chorionic gonadotropin (HCG), and gradual restoration of the HPT axis.The dependence itself may require addiction-focused psychological treatments similar to those used in other substance use disorders.Holmes closes the case with one final observation.Muscles can be measured.Strength can be tested.But insecurity has no visible weight.Sometimes the heaviest burden carried by the strongest-looking person in the room is the belief that they are still not enough.Key Takeaways* Anabolic-androgenic steroids (AAS) are synthetic derivatives of testosterone used primarily to increase muscle mass and physical appearance.* Most users are non-athletes seeking improved body image rather than sporting performance.* Typical onset of use occurs around 23 years of age, much later than most illicit substances.* AAS are distinct from corticosteroids such as prednisone.* Illicit users commonly take 10–100 times therapeutic testosterone doses through “stacking” multiple preparations.* Most users experience few psychiatric effects, but some develop hypomania, mania, psychosis, aggression, or severe irritability.* Withdrawal commonly produces hypogonadism, fatigue, depression, reduced libido, and erectile dysfunction.* Muscle dysmorphia is a major psychological driver of persistent steroid use.* Dependence develops through interacting body-image, endocrine, and reward-system mechanisms.* Long-term complications include cardiomyopathy, premature coronary artery disease, infertility, dyslipidaemia, tendon rupture, hepatic injury, and possible neurocognitive impairment.* Management requires psychological therapy, endocrine treatment, and addiction-focused interventions rather than simple detoxification.* Clinicians should actively enquire about AAS use in muscular men presenting with mood disorders, infertility, cardiovascular disease, or unexplained aggression. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe
• 
  PSYCH 090: Sedative-, Hypnotic-, or Anxiolytic-Related Disorders 13.08.2026 49นาที

  Medlock Holmes is summoned to investigate a peculiar paradox.The patients arriving at his clinic are not chasing euphoria. Many have never bought drugs illegally. They are teachers, nurses, executives, retirees, and people living with chronic anxiety or insomnia. They followed medical advice. They took their medication exactly as prescribed.Yet months-or years-later, many discover something unsettling.They no longer know whether they are taking the medication because they still need it, or because their brain has quietly adapted to its presence.Holmes begins with the brain’s principal braking system: gamma-aminobutyric acid (GABA). Under normal circumstances, GABA prevents excessive neuronal firing, maintaining calm, sleep, and emotional stability. Benzodiazepines and related sedative–hypnotics do not replace GABA; instead, they amplify its inhibitory effects, making the brain less excitable and producing anxiolysis, sedation, hypnosis, muscle relaxation, and anticonvulsant activity.Initially, the treatment works beautifully.Sleep returns.Anxiety eases.Muscles relax.But the nervous system is designed to maintain equilibrium. With continuous exposure, GABA receptors adapt. Receptor sensitivity changes, glutamate activity increases, calcium channel function shifts, and neuroendocrine systems recalibrate. The brain quietly raises its internal “accelerator” to compensate for the external “brake.”Holmes realises this is the critical distinction many clinicians overlook.Physiological dependence is not the same as addiction.A patient who develops tolerance and withdrawal after months of appropriate medical treatment has experienced normal neuroadaptation-not necessarily a substance use disorder. Addiction requires behavioural changes: compulsive use, loss of control, continued use despite harm, craving, and impairment in functioning. The distinction is clinically and ethically essential.As Holmes follows the clues, he discovers why abrupt cessation can be dangerous.Without the enhanced GABA activity, the now-adapted nervous system becomes relatively hyperexcitable. Minor symptoms include anxiety, insomnia, tremor, irritability, sweating, nausea, and autonomic activation. More severe withdrawal can produce hallucinations, psychosis, delirium, hyperthermia, and generalised tonic–clonic seizures. Barbiturate withdrawal, in particular, may be fatal if untreated.Holmes then encounters another mystery.Why are benzodiazepines generally much safer than barbiturates?The answer lies within receptor pharmacology. Benzodiazepines are positive allosteric modulators: they require endogenous GABA before exerting their effects. Barbiturates, particularly at higher concentrations, can directly activate GABA receptors, producing profound respiratory depression. This explains why benzodiazepine overdose alone is often survivable, whereas barbiturate overdose commonly causes respiratory arrest. However, combining benzodiazepines with alcohol or opioids removes this safety margin and dramatically increases mortality.The final chapter of the investigation concerns recovery.Holmes rejects dramatic detoxification. Instead, he advocates patience.Successful treatment usually involves gradual tapering-often over weeks or months-allowing the nervous system to slowly recalibrate. Longer-acting benzodiazepines such as diazepam or clonazepam are sometimes substituted to produce a smoother withdrawal. Psychological therapies, especially cognitive behavioural approaches, teach patients how to manage the anxiety that originally prompted treatment, preventing medication from remaining the sole coping strategy.Holmes closes his notebook with a final reflection.Sometimes the greatest clinical challenge is not recognising addiction.It is recognising when a patient’s dependence is simply the predictable consequence of effective medicine-and helping them leave it safely without confusing treatment with failure.Key Takeaways* Sedative-, hypnotic-, and anxiolytic-related disorders primarily involve medications that enhance GABAergic neurotransmission, especially benzodiazepines.* Physiological dependence (tolerance and withdrawal) is not synonymous with substance use disorder.* Substance use disorder requires behavioural features such as impaired control, compulsive use, craving, and continued use despite harm.* Benzodiazepines act as positive allosteric modulators of the GABA-A receptor and require endogenous GABA to exert their effects.* Barbiturates have greater overdose risk because they can directly activate GABA receptors and produce significant respiratory depression.* Tolerance develops through neuroadaptive changes involving GABA receptors, glutamate pathways, calcium channels, and stress systems.* Withdrawal symptoms range from anxiety and insomnia to seizures, delirium, hallucinations, and autonomic instability.* Abrupt cessation after prolonged treatment significantly increases withdrawal risk.* Short-acting benzodiazepines generally produce earlier withdrawal than long-acting agents.* Benzodiazepine overdose alone is often relatively safe, but combining benzodiazepines with alcohol or opioids markedly increases mortality.* Flumazenil can reverse benzodiazepine overdose in selected circumstances.* Gradual tapering is the cornerstone of withdrawal management; many patients require individualised, prolonged dose reductions.* Cognitive behavioural therapy and other psychological interventions improve successful discontinuation and long-term anxiety management.* Barbiturate withdrawal is a medical emergency because of its high risk of seizures, delirium, and death.* Good prescribing balances effective symptom relief with careful monitoring, patient education, and planned discontinuation whenever appropriate. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe
• 
  PSYCH 089: Opioid Use and Related Disorders: From Neuroscience to Treatment 12.08.2026 41นาที

  Medlock Holmes enters a city built around a remarkable hospital.Within its walls, suffering is eased. Pain is softened. Patients who could not move begin to breathe, walk, sleep, and recover. The medicines used here are powerful, ancient, and deeply valuable.Yet beyond the hospital gates, Holmes finds another city forming in the shadows.At first, the same medicines offer warmth, relief, and escape. Then tolerance develops. The dose that once brought comfort no longer works. The body adapts. The mind learns. The streets begin to reorganise around a single need: obtain the opioid, avoid withdrawal, and return to relief.Holmes follows the trail from prescription tablets to heroin, from heroin to fentanyl, from private pain to public health crisis. He discovers that opioid use disorder is not simply a problem of pleasure-seeking. It is a chronic relapsing-remitting brain disorder involving reward, motivation, memory, stress, pain, attachment, and survival.The neurobiology is central. Opioids act primarily through mu-opioid receptors, producing analgesia, euphoria, sedation, respiratory depression, and gastrointestinal effects. With repeated use, neural circuits adapt. Dopamine reward pathways are altered, stress systems become sensitised, and withdrawal becomes a powerful driver of continued use.Holmes recognises withdrawal as the body’s alarm system in reverse. Anxiety, sweating, yawning, diarrhoea, muscle aches, insomnia, rhinorrhoea, piloerection, and craving emerge when opioid signalling falls. The person may no longer be using to feel high, but to feel briefly normal.The greatest danger is overdose. Respiratory depression can silently turn sleep into coma. Fentanyl and other synthetic opioids make the margin between intoxication and death frighteningly narrow. Naloxone becomes the emergency key that can unlock the receptor and restore breathing, but it is only the beginning of treatment.The real transformation comes through sustained care. Methadone, buprenorphine, and extended-release naltrexone each act differently at the opioid receptor, but all can reduce relapse, overdose, and mortality when properly used. Psychosocial treatment, trauma-informed care, family support, harm reduction, housing, employment, and recovery communities rebuild the wider city around the person.By the end of the investigation, Holmes sees opioid treatment not as replacing one dependence with another, but as restoring biological stability so that choice, dignity, and future can return.The mystery is not whether recovery is possible.It is why society so often withholds the very treatments that make recovery more likely.Key Takeaways* Opioids include naturally occurring, semi-synthetic, and synthetic substances such as morphine, heroin, oxycodone, methadone, buprenorphine, and fentanyl.* Opioid use disorder is a chronic relapsing-remitting condition involving brain reward, stress, memory, motivation, and control systems.* Mu-opioid receptor activation produces analgesia, euphoria, sedation, miosis, constipation, and respiratory depression.* Tolerance develops with repeated opioid exposure, often leading to escalating use.* Withdrawal may include dysphoria, anxiety, muscle aches, nausea, vomiting, diarrhoea, sweating, yawning, rhinorrhoea, piloerection, insomnia, and craving.* Opioid intoxication may present with euphoria followed by apathy, impaired judgement, drowsiness, slurred speech, miosis, and impaired attention or memory.* Opioid overdose is a medical emergency characterised by coma, respiratory depression, and often pinpoint pupils.* Naloxone reverses opioid overdose by antagonising opioid receptors and restoring ventilation.* Fentanyl and other high-potency synthetic opioids have significantly increased overdose risk.* Detoxification alone is not adequate treatment and may increase overdose risk if not followed by relapse-prevention care.* Methadone is a full opioid agonist used in maintenance treatment.* Buprenorphine is a partial opioid agonist with a ceiling effect that improves safety and can block other opioids.* Naltrexone is an opioid antagonist used after detoxification to prevent relapse.* Effective treatment combines medication, psychosocial interventions, harm reduction, medical care, and long-term recovery support.* Comorbid depression, anxiety, PTSD, antisocial traits, chronic pain, hepatitis, HIV, and polysubstance use are common and require integrated care. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe
• 
  PSYCH 088: Tobacco-Related Disorders 11.08.2026 1ชม. 5นาที

  Medlock Holmes is summoned to investigate the greatest unsolved epidemic in modern psychiatry.Unlike the previous cases, there is no mystery about what causes the deaths.The evidence has been overwhelming for decades.Yet millions continue to use the substance.The mystery is not what tobacco does.The mystery is why humanity continues to smoke despite knowing the truth.Holmes begins where every psychiatrist must begin-with nicotine.Nicotine is one of the most powerfully addictive substances known, reaching the brain within seconds after inhalation. Each cigarette reinforces a rapid cycle of reward, relief from withdrawal, habit formation, and conditioned learning. Over years, smoking becomes far more than a behaviour-it becomes woven into identity, routines, relationships, stress management, and emotional regulation.As Holmes surveys the city, he notices something deeply troubling.The burden of tobacco is not shared equally.Psychiatric patients smoke at dramatically higher rates than the general population. Individuals with schizophrenia, mood disorders, anxiety disorders, substance use disorders, trauma histories, and adverse childhood experiences are disproportionately affected. Tobacco contributes substantially to the reduced life expectancy seen in severe mental illness-not because of psychiatric disease itself, but because of cardiovascular disease, respiratory illness, cancer, and other smoking-related conditions.Following the trail, Holmes uncovers an old misconception.For years, clinicians believed smoking helped psychiatric patients cope-that quitting might worsen their mental illness. Yet the evidence now tells a different story. Smoking cessation does not worsen long-term mental health. Instead, many patients experience improvements in mood, anxiety, quality of life, physical health, finances, and recovery from other addictions.Holmes next examines the neurobiology.Nicotine binds to nicotinic acetylcholine receptors, activating dopaminergic reward pathways within the mesolimbic system. Withdrawal emerges quickly because nicotine levels fall rapidly, producing irritability, anxiety, depressed mood, restlessness, poor concentration, insomnia, increased appetite, and intense craving. Smokers often continue smoking not to become intoxicated, but simply to avoid withdrawal.The investigation widens.Modern nicotine addiction extends far beyond cigarettes. Cigars, cigarellos, hookahs, smokeless tobacco, nicotine pouches, vaping devices, and electronic cigarettes all deliver nicotine through different routes, each carrying its own misconceptions regarding safety. Holmes carefully separates evidence from marketing, recognising that newer products often create new pathways into nicotine dependence, particularly among adolescents.Treatment, Holmes realises, is remarkably effective when approached systematically.Every patient should be asked about tobacco use.Every smoker should receive brief advice to quit.Every smoker should be offered evidence-based treatment.Behavioural therapies, motivational interviewing, relapse prevention, mindfulness approaches, quit-lines, and community supports work even better when combined with pharmacotherapy. Nicotine replacement therapy, bupropion, and varenicline substantially improve quit rates, while newer interventions such as transcranial magnetic stimulation continue to emerge.Finally, Holmes confronts the greatest irony of the case.The deadliest addictive disorder in psychiatry is also among the most treatable.The greatest tragedy is not that tobacco addiction exists.It is that clinicians sometimes fail to treat it.Key Takeaways* Tobacco use disorder is the most prevalent substance use disorder worldwide and remains the leading preventable cause of death.* Psychiatric patients smoke at far higher rates than the general population and experience disproportionate tobacco-related morbidity and mortality.* Nicotine rapidly reaches the brain, activating nicotinic acetylcholine receptors and mesolimbic dopamine reward pathways.* Dependence is maintained through both positive reinforcement and avoidance of withdrawal.* DSM-5 diagnoses Tobacco Use Disorder using the standard substance use disorder criteria, graded as mild, moderate, or severe.* Nicotine withdrawal typically includes irritability, anxiety, depressed mood, insomnia, restlessness, poor concentration, increased appetite, and craving.* Withdrawal symptoms usually peak within 1–3 days and improve over 2–3 weeks, although craving may persist for months.* Smoking cessation generally improves rather than worsens long-term mental health outcomes.* Tobacco cessation also improves recovery from many other substance use disorders.* Evidence-based psychosocial interventions include motivational interviewing, behavioural therapy, relapse prevention, mindfulness, quit-lines, and support programmes.* First-line pharmacotherapies include nicotine replacement therapy, bupropion, and varenicline.* Combining behavioural therapy with pharmacotherapy produces the highest quit rates.* Smoking induces CYP1A2 enzymes; stopping smoking increases blood concentrations of medications such as clozapine and olanzapine, requiring careful dose adjustment.* Clinicians should routinely assess smoking status using the “5 A’s”: Ask, Advise, Assess, Assist, and Arrange follow-up.* Prevention strategies include taxation, smoke-free legislation, advertising restrictions, adolescent prevention, and culturally appropriate public health interventions. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe
• 
  PSYCH 087: Inhalant-Related Disorders 10.08.2026 47นาที

  Medlock Holmes is called to investigate a troubling mystery among the youngest citizens of the city.There is no dealer on the street corner.No hidden laboratory.No expensive supply chain.Instead, the clues are ordinary household objects: glue, paint thinner, spray cans, lighter fluid, petrol, correction fluid, cleaning products, and aerosol dusters.At first, the city dismisses the danger.These are not “real drugs”, people say.They are products.They are everywhere.But Holmes knows that availability can be the most dangerous disguise of all.Inhalants are volatile substances that rapidly vaporise and are inhaled for psychoactive effects. Their intoxication arrives quickly because the lungs deliver these chemicals directly into the bloodstream and then to the brain. Within minutes, a young person may experience euphoria, disinhibition, dizziness, slurred speech, unsteady gait, hallucinations, confusion, or collapse.Holmes notices that inhalant use is especially common in early adolescence. The appeal is obvious: the substances are cheap, legal, easy to conceal, and difficult to detect on routine toxicology screens. Yet the danger is profound. A single episode can cause suffocation, aspiration, burns, trauma, seizures, coma, respiratory depression, or sudden cardiac death.As Holmes follows the trail deeper, he discovers that chronic inhalant use is not merely a behavioural problem. It is a toxic assault on the body. The brain, rich in lipids and myelinated tissue, is particularly vulnerable. Long-term use can damage white matter, impair memory and executive functioning, cause cerebellar problems, produce neuropathy, and contribute to major or mild neurocognitive disorder.The investigation also reveals a familiar pattern of psychiatric complexity. Inhalant use is often associated with conduct disorder, trauma, neglect, suicidality, mood and anxiety disorders, antisocial traits, and polysubstance use. For some adolescents, experimentation stops quickly. For others, inhalants become an early warning signal of a much broader developmental pathway involving impulsivity, risk-taking, marginalisation, and future substance dependence.Treatment is difficult because the evidence base is limited. There is no simple medication that reverses inhalant use disorder. Care requires careful medical assessment, management of intoxication, attention to neurological and cognitive injury, family work, trauma-informed care, school and social support, relapse prevention, and treatment of comorbid psychiatric and substance use disorders.By the end of the case, Holmes realises that inhalants are dangerous precisely because they are ordinary.The threat does not always arrive wearing the face of crime.Sometimes it sits quietly on a shelf, waiting to be misunderstood.Key Takeaways* Inhalants are volatile substances inhaled for psychoactive effects.* Common sources include glues, paints, thinners, fuels, aerosols, cleaning products, correction fluids, and dusters.* Use is most common in younger adolescents and tends to decline with age.* Inhalant intoxication can cause euphoria, disinhibition, dizziness, slurred speech, ataxia, hallucinations, confusion, stupor, coma, or death.* A single episode may be fatal through arrhythmia, suffocation, aspiration, respiratory depression, burns, trauma, or seizures.* Routine drug screens often miss inhalant use.* Clues include chemical odour, stained clothing, solvent-soaked rags, bags, aerosol cans, or perioral/perinasal rash.* Chronic use can cause neurological injury, white matter damage, cognitive impairment, neuropathy, cerebellar signs, and neurocognitive disorder.* Inhalant use is strongly associated with conduct disorder, trauma, suicidality, polysubstance use, mood disorders, anxiety disorders, and social adversity.* Inhalant-induced psychiatric disorders may include delirium, psychosis, depressive disorder, anxiety disorder, and neurocognitive disorder.* Management of intoxication is mainly supportive, with careful monitoring of airway, breathing, circulation, consciousness, and cardiac risk.* Agitation should be managed cautiously because physical excitement may increase arrhythmia risk.* Benzodiazepines may worsen respiratory depression during acute intoxication and require caution.* Treatment of inhalant use disorder usually requires broad biopsychosocial care rather than substance-specific medication.* Prevention, early recognition, family involvement, and community support are especially important. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe
• 
  PSYCH 086: Hallucinogen-Related Disorders 09.08.2026 46นาที

  Medlock Holmes is called to investigate a series of extraordinary reports.One witness describes colours that seem alive. Another believes time has stopped. A third feels completely detached from their own body, while another speaks of overwhelming love, profound spiritual insight, or terrifying paranoia. Some recover within hours, while others continue to experience disturbing visual phenomena months or even years later.At first glance, every case appears to point towards severe mental illness.Yet Holmes notices an important clue.These experiences all follow exposure to substances capable of profoundly altering consciousness.This chapter explores the fascinating and rapidly evolving world of hallucinogen-related disorders. Unlike many other psychoactive substances, hallucinogens primarily alter perception, awareness, emotion, and the sense of self while often leaving consciousness intact. Rather than simply causing intoxication, they reshape how reality itself is experienced.Holmes discovers that “hallucinogen” is actually an umbrella term covering remarkably different substances. Classic psychedelics such as LSD, psilocybin, mescaline and DMT primarily act through serotonin receptors and produce vivid perceptual changes and altered states of consciousness. Dissociative agents such as ketamine and PCP disrupt the normal integration of sensory information, creating feelings of detachment from the body and environment. MDMA occupies another category altogether, enhancing emotional connectedness and empathy while also carrying significant medical risks. Other naturally occurring compounds, including salvinorin A and ibogaine, produce unique alterations of consciousness through entirely different neurochemical pathways.As Holmes interviews each individual, he realises that the same substance can produce vastly different experiences depending on the person, their expectations, and the environment in which it is taken. The concepts of “set” and “setting” emerge as critical determinants of whether the experience becomes therapeutic, frightening, enlightening, or dangerous.Most episodes resolve without lasting harm, but some do not.Holmes encounters individuals overwhelmed by panic during intoxication, others developing prolonged psychotic symptoms, and some experiencing persistent visual disturbances long after the drug has left their body. Hallucinogen Persisting Perception Disorder (HPPD) reminds him that, for a small number of people, altered perception can continue long after the original experience has ended, creating significant distress despite intact insight.The chapter also explores one of psychiatry’s most intriguing paradoxes.For decades these substances were viewed almost exclusively as drugs of misuse. Today, carefully controlled clinical research is once again investigating psychedelic-assisted therapies for treatment-resistant depression, post-traumatic stress disorder, addiction, and end-of-life distress. Ketamine has already become an established treatment for resistant depression, while other compounds continue to be evaluated in rigorous clinical trials.Holmes recognises that this changing landscape creates new responsibilities for clinicians. Patients may increasingly ask about psychedelic therapies, experiment with self-treatment, or present with complications of recreational use. Understanding both the potential benefits and the risks becomes essential.By the conclusion of the investigation, Holmes reaches a balanced perspective.Hallucinogens are neither miracle medicines nor simply dangerous drugs.They are powerful tools capable of profoundly altering consciousness. Used in uncontrolled settings, they may produce medical emergencies, psychological trauma, or persistent psychiatric disorders. Used carefully within structured therapeutic environments, they may eventually transform aspects of psychiatric treatment.The challenge for modern psychiatry is to approach these substances with curiosity, scientific rigour, and clinical caution-avoiding both fear and uncritical enthusiasm.Key Takeaways* Hallucinogens alter perception, consciousness, emotion, and sense of self without typically causing delirium.* Major classes include classic psychedelics, dissociatives, entactogens, and several naturally occurring compounds.* Different hallucinogens act through different neurochemical mechanisms.* “Set” and “setting” strongly influence the psychological experience.* Acute intoxication may present with anxiety, panic, perceptual distortions, paranoia, or psychosis.* PCP and ketamine are more likely to produce severe behavioural disturbance and medical complications.* Hallucinogen Persisting Perception Disorder (HPPD) causes recurrent perceptual disturbances after drug use.* Hallucinogen-induced psychosis may occur, particularly in vulnerable individuals.* Management focuses on supportive care, reassurance, benzodiazepines when required, and treatment of medical complications.* Ketamine is now established in psychiatric treatment, while psilocybin and MDMA continue to be investigated for therapeutic use.* Clinicians should distinguish substance-induced disorders from primary psychiatric illnesses.* Understanding both the risks and therapeutic potential of psychedelics is becoming increasingly important for modern psychiatric practice. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe
• 
  PSYCH 085: Cannabis-Related Disorders 08.08.2026 58นาที

  Cannabis is often viewed as harmless, natural, or even medicinal, yet its relationship with mental health is far more complex. In this episode, Medlock Holmes investigates how THC alters brain function, why some people develop dependence while others do not, and the growing evidence linking cannabis with anxiety, psychosis, cognitive impairment, and withdrawal. As cannabis becomes increasingly potent and widely available, Holmes uncovers the delicate balance between therapeutic potential and psychiatric risk.Key Takeaways* Cannabis is the most widely used illicit drug worldwide.* THC is the primary psychoactive cannabinoid and acts mainly through CB1 receptors in the brain.* Modern cannabis products contain much higher THC concentrations than in previous decades.* Cannabis can be smoked, vaped, ingested as edibles, or consumed as concentrated extracts.* Acute intoxication commonly causes euphoria, relaxation, altered perception, impaired attention, poor short-term memory, and slowed reaction time.* Motor coordination and driving ability are significantly impaired during intoxication.* Regular cannabis use can lead to Cannabis Use Disorder, characterised by impaired control, craving, tolerance, withdrawal, and continued use despite harm.* Approximately 1 in 10 people who ever use cannabis develop dependence, rising to around 1 in 3 among regular users.* Withdrawal usually begins within 24–48 hours and includes irritability, anxiety, insomnia, reduced appetite, restlessness, depressed mood, sweating, tremor, headache, and abdominal discomfort.* Heavy cannabis use is associated with poorer educational outcomes, reduced cognitive performance, and impaired memory, particularly with early adolescent use.* High-potency cannabis increases the risk of psychotic symptoms and may precipitate schizophrenia in genetically vulnerable individuals.* Continued cannabis use after a first episode of psychosis is associated with poorer clinical outcomes and higher relapse rates.* Cannabis may also worsen anxiety, trigger panic attacks, and contribute to cannabinoid hyperemesis syndrome in chronic heavy users.* Acute cannabis use increases heart rate and can pose cardiovascular risks in susceptible individuals.* There is no approved pharmacological treatment for Cannabis Use Disorder.* The most effective treatments combine motivational enhancement therapy (MET), cognitive behavioural therapy (CBT), relapse prevention, contingency management, and family-based interventions for adolescents.* Medicinal cannabinoids have evidence for selected conditions including chemotherapy-induced nausea, multiple sclerosis spasticity, certain epilepsies, and some chronic pain conditions, but evidence remains limited for many psychiatric disorders. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe
• 
  PSYCH 084: Caffeine-Related Disorders 07.08.2026 43นาที

  Every morning, before the city truly awakens, Medlock Holmes notices a remarkable ritual.Office lights flicker on.Coffee machines begin to hiss.Kettles whistle.Students cradle steaming mugs.Doctors begin ward rounds with takeaway cups in hand.Parents finally feel awake after the first sip.Unlike the illicit drugs Holmes has investigated before, no one hides this substance.It is celebrated.Shared.Offered to guests.Embedded within culture itself.Yet Holmes is puzzled.How can the world’s most socially accepted psychoactive substance also be capable of intoxication, withdrawal, anxiety, insomnia, dependence, and addiction?His newest investigation begins not in a crime scene-but in a café.Holmes quickly discovers that caffeine is the most widely consumed psychoactive drug in the world, with around 90% of adults consuming it regularly. It is naturally present in coffee, tea, cocoa, yerba mate and many other plants, while manufacturers also add it to soft drinks, energy drinks, medications, dietary supplements and foods.Unlike amphetamines or cocaine, caffeine works primarily by blocking adenosine receptors.Adenosine normally acts like the brain’s biological brake pedal.Throughout the day, adenosine gradually accumulates.The more adenosine binds to its receptors, the sleepier we become.Caffeine disguises itself as adenosine.It occupies the receptor without activating it.The brake disappears.The brain becomes more alert.Indirectly, dopamine signalling also increases, producing greater motivation, attention and reward.Holmes smiles.“The engine,” he says, “was never made stronger.”“You merely disconnected the brakes.”The chapter explores the remarkable pharmacology of caffeine.After ingestion, caffeine is rapidly absorbed, reaching peak blood levels within approximately 30–60 minutes. Its average half-life is four to six hours, although this varies considerably depending on genetics, pregnancy, oral contraceptive use, smoking, liver disease and interacting medications. Slow metabolisers may experience caffeine’s effects for far longer than expected.Holmes begins interviewing patients.Each tells a different story.A medical student drinks two coffees before an examination and feels focused.A lawyer drinks six coffees and cannot stop pacing.A teenager consumes multiple energy drinks before sport and develops palpitations.A psychiatrist cannot function until the second cup each morning.The same molecule.Different brains.Different outcomes.Holmes learns that caffeine’s effects are strongly dose dependent.Low to moderate doses (around 20–200 mg) typically improve alertness, energy, concentration, mood and motivation while reducing fatigue.At higher doses (usually ≥400 mg), benefits begin to disappear.Instead, anxiety, nervousness, tremor, jitteriness and restlessness emerge. Performance may actually worsen despite feeling more awake.He remarks:“The dose decides whether caffeine becomes an ally-or an adversary.”His next investigation concerns caffeine intoxication.Unlike alcohol intoxication, most people never intend to become intoxicated with caffeine.Instead, it happens accidentally.Extra coffees during deadlines.Multiple energy drinks during examinations.Workout supplements combined with coffee.Weight-loss tablets.Cold medications.The total quietly accumulates.DSM-5-TR suggests intoxication generally follows recent consumption well above 250 mg, although more severe presentations often involve much larger doses. Typical symptoms include:* Restlessness* Nervousness* Excitement* Insomnia* Diuresis* Gastrointestinal upset* Muscle twitching* Rambling speech* Tachycardia* Psychomotor agitationSevere overdose may produce vomiting, seizures, delirium, arrhythmias and, rarely, death. Fatal toxicity is uncommon and usually involves caffeine tablets or powder rather than beverages.Holmes notices something interesting.Patients rarely realise that their “panic attack” may actually be caffeine intoxication.The next mystery surprises him even more.Not intoxication.Withdrawal.One woman develops a terrible headache every Sunday morning.Another develops “influenza” during religious fasting.A surgeon repeatedly experiences postoperative headaches.Each mystery has the same explanation.No caffeine.The chapter explains that regular caffeine use produces genuine physical dependence. Withdrawal typically begins 12–24 hours after cessation, peaks during the first 48 hours and usually resolves within two to nine days. The hallmark symptom is headache, but fatigue, drowsiness, depressed mood, poor concentration, irritability, nausea, muscle aches and flu-like symptoms are also common. Even relatively modest daily consumption (around 100 mg) may produce withdrawal in susceptible individuals.Holmes reflects:“People often mistake withdrawal for illness.”“In reality, they are experiencing the absence of something they believed they never depended upon.”Another patient arrives convinced she has developed an anxiety disorder.Holmes notices something unusual.She drinks eight large coffees every day.Her anxiety worsens steadily throughout the afternoon.Rather than prescribing anxiolytics immediately, Holmes performs a simple experiment.He gradually reduces her caffeine intake.The anxiety disappears.The chapter describes caffeine-induced anxiety disorder, recognising that caffeine may precipitate panic attacks or clinically significant anxiety, particularly in susceptible individuals or those with existing anxiety disorders. A trial of caffeine reduction or abstinence is often diagnostically useful before escalating pharmacological treatment.Sleep presents another paradox.Many people drink coffee because they are tired.Later, they cannot sleep because they drank coffee.The following morning they require more coffee.Holmes sketches a circle.Fatigue.Coffee.Poor sleep.More fatigue.More coffee.The chapter explains caffeine-induced sleep disorder, most commonly insomnia. Even 200 mg consumed before bedtime may delay sleep onset, reduce total sleep time and impair sleep quality, while caffeine taken earlier in the day may still affect sleep later that night in sensitive individuals. Although habitual users develop partial tolerance, the sleep-disrupting effects are never completely eliminated.Holmes is initially reluctant to believe that caffeine can produce a genuine use disorder.After all...People joke about “coffee addiction.”The chapter suggests the joke is sometimes true.DSM-5-TR currently lists Caffeine Use Disorder as a condition for further study.The proposed diagnosis requires three core features:* Persistent unsuccessful attempts to reduce caffeine.* Continued use despite physical or psychological harm.* Withdrawal leading to continued consumption.Research suggests that approximately 8–13% of regular caffeine users may meet proposed diagnostic criteria, with many reporting significant distress, anxiety, insomnia and repeated failed attempts to stop.Holmes quietly observes:“Addiction is not measured by legality.”“It is measured by loss of choice.”Treatment proves refreshingly simple-but not always easy.Unlike illicit stimulants, complete abstinence is often unnecessary.Most patients benefit from gradual reduction.The authors recommend:* Educating patients about hidden caffeine sources.* Recording daily caffeine intake.* Setting realistic reduction goals.* Reducing intake by approximately 25% each week.* Substituting decaffeinated alternatives.* Using behavioural strategies similar to other substance use disorders.Abrupt cessation is generally discouraged because withdrawal itself often causes relapse. Randomised studies demonstrate that structured behavioural reduction programmes can substantially reduce caffeine consumption while improving anxiety, sleep and quality of life.As Holmes leaves the café, he notices something he had overlooked all morning.Nobody drinks coffee simply because it tastes pleasant.Some drink it to wake.Some to work.Some to think.Some merely to feel normal.He realises that caffeine is unique.Unlike many psychoactive drugs, it quietly weaves itself into ordinary life until its absence becomes louder than its presence.The mystery, Holmes concludes, is not why caffeine changes the brain.The mystery is how easily we forget that it does.Key Takeaways* Caffeine is the world’s most widely consumed psychoactive substance.* It acts primarily by antagonising adenosine receptors, indirectly increasing dopaminergic activity.* Low doses improve alertness and concentration, whereas high doses commonly cause anxiety, jitteriness and insomnia.* Caffeine intoxication presents with restlessness, tachycardia, gastrointestinal symptoms, tremor and psychomotor agitation.* Chronic caffeine use produces genuine physical dependence and a well-defined withdrawal syndrome.* Withdrawal usually begins within 12–24 hours and is characterised by headache, fatigue, low mood and impaired concentration.* Caffeine may induce clinically significant anxiety and sleep disorders, particularly in susceptible individuals.* Caffeine Use Disorder is recognised in DSM-5-TR as a condition for further study.* Behavioural treatment focuses on gradual reduction rather than abrupt cessation.* Clinicians should routinely assess caffeine intake when evaluating anxiety, insomnia, headaches and unexplained physical symptoms. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe
• 
  PSYCH 082: Alcohol-Related Disorders 05.08.2026 1ชม. 6นาที

  Medlock Holmes is invited to investigate a city where one establishment appears to be at the centre of almost every celebration.People gather there after work.Families celebrate milestones there.Business deals are made there.Victories are toasted there.At first glance, the tavern seems woven naturally into the life of the city.Yet Holmes begins noticing a different pattern.The same people keep returning-not because they wish to celebrate, but because they no longer know how to stop.Relationships begin to fracture.Careers slowly decline.Health deteriorates.Anxiety and depression become more common.What once appeared to offer freedom gradually becomes a source of dependence.This chapter explores alcohol-related disorders-the most common substance use disorders encountered in psychiatric practice and among the most misunderstood.Alcohol is unique because it is both socially accepted and pharmacologically powerful. It acts throughout the brain, altering inhibitory and excitatory neurotransmission, influencing dopamine reward pathways, impairing judgement, memory, sleep, and emotional regulation. With repeated exposure, the brain adapts, leading to tolerance, withdrawal, craving, and eventually dependence in vulnerable individuals.Holmes soon realises that alcohol problems rarely present in obvious ways. Many people with alcohol use disorder maintain employment, support families, and function successfully for years. The disorder often hides behind symptoms such as anxiety, depression, insomnia, relationship conflict, cognitive impairment, or unexplained medical illness rather than obvious intoxication.As his investigation deepens, Holmes discovers that alcohol affects virtually every organ system.The liver struggles to detoxify increasing amounts of ethanol.The heart weakens.Peripheral nerves become damaged.The immune system falts.Sleep architecture fragments.Memory begins to fail.Even brief episodes of intoxication may leave permanent gaps in memory through alcohol-induced blackouts, while prolonged heavy use increases the risk of Wernicke–Korsakoff syndrome and alcohol-related neurocognitive disorders.The chapter also explores withdrawal-the brain’s response when alcohol suddenly disappears.What was once chemically suppressed becomes excessively active.Tremor.Sweating.Anxiety.Insomnia.Hypertension.Seizures.In severe cases, delirium tremens emerges as a medical emergency requiring urgent treatment. Holmes recognises that safe management depends upon careful assessment, timely benzodiazepine therapy, and close monitoring rather than simply asking someone to “stop drinking.”Another important lesson concerns psychiatric diagnosis.Heavy alcohol use can produce depression, anxiety, psychosis, sleep disturbance, and cognitive impairment that closely resemble primary psychiatric disorders. Holmes learns that chronology is one of the clinician’s greatest diagnostic tools. Did the psychiatric symptoms precede heavy drinking, or did they emerge during intoxication and withdrawal? Careful timelines often reveal whether symptoms are alcohol-induced or represent independent psychiatric illnesses requiring parallel treatment.Treatment extends well beyond detoxification.Holmes discovers that recovery involves rebuilding an entire way of living.Motivation must be strengthened.Triggers identified.Relationships repaired.Relapse anticipated rather than feared.Evidence-based psychological therapies, mutual support groups, family involvement, and medications such as acamprosate and naltrexone each contribute to long-term recovery by addressing different parts of the addiction cycle.As Holmes leaves the city, he looks back at the tavern.It has not changed.People still gather there.Some will drink safely throughout their lives.Others will unknowingly begin a journey towards dependence.The difference lies not simply in the substance itself, but in the complex interaction between biology, psychology, environment, and vulnerability.Alcohol is neither wholly friend nor enemy.Like many powerful tools, its impact depends upon the relationship people develop with it-and recognising when that relationship has quietly shifted from choice to compulsion.Key Takeaways* Alcohol use disorder is one of the most common psychiatric disorders worldwide.* Alcohol affects multiple neurotransmitter systems, producing intoxication, tolerance, withdrawal, and dependence.* Many individuals with alcohol use disorder remain employed and outwardly functional.* Heavy alcohol use can mimic depression, anxiety, psychosis, and cognitive disorders.* Careful chronology helps distinguish alcohol-induced disorders from independent psychiatric illness.* Withdrawal ranges from mild tremor to life-threatening delirium tremens.* Alcohol contributes to significant neurological, hepatic, cardiovascular, gastrointestinal, and cognitive complications.* Assessment includes history, collateral information, laboratory markers, and screening tools such as the AUDIT.* Long-term treatment combines psychological therapies, relapse prevention, social support, and selected medications.* Recovery involves rebuilding a sustainable life rather than simply stopping alcohol consumption. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe
• 
  PSYCH 081: Substance Use Disorders: Introduction 04.08.2026 43นาที

  Imagine Medlock Holmes arriving in a magnificent city renowned for one remarkable feature.Every citizen possesses complete freedom.Every street offers choices.Every marketplace presents opportunities.Every day, thousands of decisions are made.Which road to follow.Which people to trust.Which risks to take.Which pleasures to pursue.At the centre of the city stands the Hall of Choice.Inside, an intricate council carefully weighs every decision.Reason speaks.Memory offers advice.Emotion contributes experience.Future consequences are considered.Rewards are balanced against risks.Normally, the system works beautifully.Citizens enjoy pleasure without becoming enslaved by it.They recover from disappointment.They learn from mistakes.They adapt.Then Holmes notices something unsettling.Certain visitors begin arriving in the city.Some carry bottles.Others offer powders.Some bring pills.Others introduce smoke, vapour, crystals, or injections.At first, these visitors seem harmless.They promise relief.Confidence.Energy.Sleep.Escape.Pleasure.The citizens welcome them.Nothing appears unusual.But gradually, something changes.The Hall of Choice no longer governs the city.Its conversations become quieter.Its influence weakens.Meanwhile, another building grows larger with every passing day.The House of Reward.Here, powerful messengers flood the city with signals of pleasure, relief, and desire.Each visit strengthens its authority.Each return becomes easier.Each absence becomes harder to tolerate.Soon, the city’s choices no longer feel like choices at all.Holmes realises he is not investigating a failure of morality.He is investigating a disease of decision-making.This chapter introduces substance use disorders as chronic biopsychosocial illnesses that reshape the brain, behaviour, and environment together.Addiction is not defined simply by the presence of a substance.It is defined by a pattern.Repeated use despite accumulating harm.Powerful cravings.Difficulty reducing or stopping.Loss of control.The consequences spread throughout the city.Relationships begin to fracture.Employment suffers.Physical health deteriorates.Mental illness becomes more severe.Communities feel the burden.Families struggle to understand why promises repeatedly become broken.Holmes discovers that modern psychiatry no longer views addiction as a failure of willpower.Instead, it recognises an illness arising from the interaction of biology, psychology, social circumstances, trauma, stress, learning, and environment.The chapter also introduces the language clinicians use to understand these disorders.Gone is the older distinction between “abuse” and “dependence.”Instead, substance use disorders exist along a continuum of severity.Some individuals experience relatively mild impairment.Others develop profound disruption affecting nearly every aspect of life.The degree of illness matters because treatment must be matched to need.As Holmes continues his investigation, he travels through different districts of the city.One neighbourhood struggles with alcohol.Another with opioids.Others face stimulants, cannabis, tobacco, sedatives, hallucinogens, inhalants, and newer synthetic substances.Although each district has unique challenges, Holmes notices that they all share remarkably similar patterns.The substances differ.The disease does not.The investigation then widens beyond individual patients.Holmes steps onto a tower overlooking the entire landscape.He sees waves of addiction moving through populations.The opioid crisis.The rise of fentanyl.Increasing alcohol-related harm.The growing use of stimulants.Changing cannabis laws.The emergence of vaping.Each reflects the complex interaction between medicine, public policy, economics, culture, and human behaviour.Yet Holmes also finds reasons for hope.Recovery centres stand throughout the city.Doctors.Psychologists.Peer recovery coaches.Families.Support groups.Medications.Behavioural therapies.Community programmes.No single intervention rebuilds the city alone.Recovery is constructed through many pathways working together.The greatest lesson of the chapter becomes increasingly clear.The opposite of addiction is not simply abstinence.It is the gradual restoration of choice.As Holmes leaves the Hall of Choice, its lights begin to shine once again.Not because temptation has disappeared.But because the city’s ability to choose its future has slowly returned.Key Takeaways* Substance use disorders are chronic biopsychosocial diseases rather than moral failings.* Addiction is characterised by impaired control, craving, continued use despite harm, and physiological adaptation.* DSM-5-TR conceptualises substance use disorders along a spectrum of severity rather than separate categories of abuse and dependence.* Biological vulnerability, psychological factors, trauma, social influences, and environmental circumstances all contribute to addiction.* Different substances affect the brain in different ways but share common underlying mechanisms involving reward and impaired decision-making.* Substance use disorders commonly coexist with other psychiatric disorders and significantly increase morbidity and mortality.* Public health crises, including the opioid epidemic and increasing stimulant use, demonstrate the societal impact of addiction.* Effective treatments include medications, psychological therapies, peer support, and long-term recovery-oriented care.* Recovery often involves periods of remission and relapse, similar to other chronic medical illnesses.* Successful treatment focuses not only on reducing substance use but on restoring health, functioning, and the ability to make autonomous choices. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe
• 
  PSYCH 080: Cognitive Disorders Due to Another Medical Condition or Substance 03.08.2026 56นาที

  Imagine Medlock Holmes arriving at a grand command centre responsible for coordinating an entire city.The command centre appears sophisticated and highly organised. It manages communication, planning, navigation, memory, and decision-making for every district.One day, however, the operators begin making mistakes.Messages are delayed.Instructions become confused.Important information is misplaced.Decision-making becomes unreliable.At first, observers assume the command centre itself is failing.Yet Holmes notices something unusual.The problems are not originating within the command centre.Instead, disruptions are arriving from elsewhere.A contaminated water supply.A failing power station.Toxic fumes entering the ventilation system.Damaged communication cables.The command centre is responding to problems occurring throughout the wider city.The command centre represents the brain.The wider city represents the body.This chapter explores cognitive disorders that arise not from primary neurodegenerative disease, but from other medical conditions, substances, medications, toxins, or systemic illnesses affecting brain function.A central lesson emerges immediately: cognition is extraordinarily dependent upon the health of the entire organism.The brain requires oxygen, nutrients, hormonal regulation, immune stability, metabolic balance, and uninterrupted communication with the rest of the body. When these systems become disrupted, cognitive symptoms may be among the earliest and most prominent signs.As Holmes investigates, he encounters a remarkable variety of causes.Endocrine disorders alter cognition through hormonal imbalance.Liver and kidney disease allow toxic substances to accumulate.Nutritional deficiencies impair neural function.Autoimmune diseases generate inflammatory disturbances.Infections affect the brain directly or indirectly.Sleep disorders compromise attention and memory.Cardiovascular disease reduces cerebral blood flow.Neurological conditions interfere with neural communication.In every case, the cognitive symptoms are real, but their origin lies beyond the brain itself.The chapter also explores the cognitive effects of substances.Holmes enters another district where medications, alcohol, recreational drugs, environmental toxins, and withdrawal states influence the city’s functioning.Some substances impair attention.Others affect memory.Some slow thinking.Others create confusion, agitation, or altered awareness.The pattern of impairment often provides clues regarding the underlying cause.A key theme is reversibility.Unlike many neurodegenerative disorders, cognitive impairment caused by medical conditions or substances may improve substantially when the underlying problem is identified and treated.Correcting a vitamin deficiency.Managing thyroid disease.Treating infection.Stopping a problematic medication.Addressing substance misuse.Restoring metabolic balance.The earlier the cause is recognised, the greater the potential for recovery.Holmes quickly learns that clinicians must resist premature conclusions.Not every memory complaint represents dementia.Not every concentration problem reflects psychiatric illness.Not every episode of confusion indicates primary brain disease.Sometimes the most important diagnostic question is not “What is happening in the brain?” but rather “What is happening elsewhere that is affecting the brain?”The chapter highlights the importance of comprehensive assessment, including medical history, physical examination, laboratory testing, medication review, neuroimaging, and collateral information.The brain cannot be assessed in isolation from the body that supports it.As Holmes reaches the centre of the command complex, he discovers a vast network connecting every organ system to the city’s central operations.Signals arrive continuously from the heart, liver, kidneys, endocrine glands, immune system, bloodstream, and environment.The lesson becomes unmistakable.The brain does not function alone.Cognitive disorders due to medical conditions or substances remind us that mental functioning depends upon the health of an entire interconnected system.For the skilled clinician, recognising those connections may transform a progressive decline into a treatable condition.Key Takeaways* Cognitive impairment may arise from medical conditions affecting brain function.* Endocrine, metabolic, infectious, autoimmune, cardiovascular, nutritional, and neurological disorders can all impair cognition.* Medications, alcohol, recreational substances, toxins, and withdrawal states may cause significant cognitive symptoms.* Careful medical assessment is essential when evaluating cognitive complaints.* Some causes of cognitive impairment are potentially reversible.* Differential diagnosis is critical to avoid misclassifying treatable conditions as neurodegenerative disease.* Laboratory testing, medication review, and physical examination are important components of assessment.* Cognitive symptoms often reflect systemic illness rather than primary brain pathology.* Early identification and treatment improve outcomes.* The brain functions within a larger biological system and cannot be understood in isolation. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe
• 
  PSYCH 079: Mild Cognitive Impairment and Amnestic Disorders 02.08.2026 52นาที

  Imagine Medlock Holmes returning once more to the great library of the mind.Unlike the previous chapter, the library is still functioning remarkably well.The catalogue remains largely intact.Visitors can still find most of the books they need.The librarians continue their work.The building remains operational.Yet Holmes notices subtle signs that something has changed.A librarian takes longer to locate a familiar volume.A catalogue entry requires a second search.A book is occasionally misplaced before being found again.The library continues to function, but not with the effortless efficiency it once possessed.This is the world of Mild Cognitive Impairment (MCI).The chapter explores a state that occupies the space between normal cognitive ageing and major neurocognitive disorder. Individuals experience measurable cognitive decline, yet their overall independence remains largely preserved.Holmes quickly learns that ageing itself is not a disease.Many cognitive processes change over time. Names may take longer to retrieve. New information may require more repetition. Processing speed may slow slightly.These changes are expected.The challenge lies in determining when such changes exceed what would normally be anticipated.As Holmes investigates, he discovers that Mild Cognitive Impairment represents an important transitional territory.Objective evidence of cognitive decline exists, often confirmed through clinical assessment or neuropsychological testing. However, the individual continues to manage daily life with relative independence.The library is functioning, but its systems are becoming less efficient.The chapter pays particular attention to amnestic disorders.Within one wing of the library, Holmes observes a specialised archive responsible for memory formation and retrieval.The challenge is not simply forgetting where a book was placed.Rather, the system responsible for recording new information struggles to create reliable entries in the catalogue.Recent events become difficult to retain.New learning becomes less efficient.Questions may be repeated because the memory of asking them was never firmly stored.Holmes discovers that amnestic disorders can arise from many causes.Some result from neurological disease.Others emerge following head injury, nutritional deficiencies, substance use, metabolic disturbances, infections, or damage to structures critical for memory processing.Not all memory disorders are progressive.Some remain stable.Others improve if the underlying cause can be treated.A central theme of the chapter is uncertainty.Not everyone with Mild Cognitive Impairment develops dementia.Some individuals remain stable for years.Some improve.Others progress to major neurocognitive disorders.The clinician’s task is therefore not merely to identify impairment but to understand its pattern, severity, likely cause, and future implications.As Holmes explores further, he notices something often overlooked.People with Mild Cognitive Impairment are frequently aware of their difficulties.Unlike advanced neurocognitive disorders, where insight may diminish, individuals often recognise changes in memory, concentration, or mental efficiency.This awareness can generate anxiety, frustration, fear, and concern about the future.The emotional impact of cognitive change becomes part of the story.The chapter also highlights the importance of early assessment.Recognising subtle cognitive changes allows clinicians to investigate reversible causes, monitor progression, implement risk reduction strategies, and support individuals and families before substantial functional decline occurs.Standing within the library’s memory archive, Holmes observes shelves that remain largely intact yet require increasing effort to navigate.The building still functions.The knowledge remains present.The challenge lies in accessing it reliably.The lesson becomes clear.Mild Cognitive Impairment and amnestic disorders are not simply disorders of forgetting.They are disorders of information processing, storage, and retrieval that occupy a crucial boundary between healthy cognitive ageing and more significant cognitive decline.For clinicians, recognising this boundary may be one of the most important opportunities for early intervention and understanding.Key Takeaways* Mild Cognitive Impairment (MCI) involves measurable cognitive decline that exceeds expected ageing.* Individuals with MCI generally maintain independence in everyday functioning.* MCI occupies an intermediate position between normal ageing and major neurocognitive disorder.* Not all individuals with MCI progress to dementia.* Amnestic disorders primarily affect memory formation, storage, or retrieval.* Memory impairment may result from neurological, medical, nutritional, traumatic, infectious, or substance-related causes.* Neuropsychological assessment is often helpful in characterising cognitive deficits.* Early recognition allows investigation of reversible causes and monitoring over time.* Insight is often preserved in MCI, contributing to emotional distress and anxiety.* Assessment should consider cognition, function, emotional wellbeing, and future risk. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe
• 
  PSYCH 083: Stimulant-Related Disorders 06.08.2026 59นาที

  Medlock Holmes is summoned to investigate a city that never seems to sleep.The streets remain alive long after midnight.Factories work around the clock.Students study without rest.Traders chase impossible fortunes.Artists paint through the night.Everyone appears driven by an invisible force that promises endless energy, relentless focus, and extraordinary productivity.Yet Holmes quickly notices another pattern.The faster the city moves, the more fragile it becomes.People who once brimmed with confidence now pace the streets in terror.Windows are barricaded against imagined enemies.Brilliant careers collapse into paranoia.Bodies begin to fail long before minds are willing to stop.Holmes soon realises that he is confronting the world of stimulant-related disorders.Stimulants-including cocaine, amphetamines, methamphetamine, prescription stimulants such as methylphenidate, and newer synthetic cathinones (”bath salts”)-all share a common feature: they dramatically increase alertness, energy, confidence, and reward by enhancing dopaminergic neurotransmission. Although they differ chemically, they converge upon the brain’s reward circuitry, particularly the dopamine pathways linking the ventral tegmental area to the nucleus accumbens.Unlike alcohol, whose effects slow the nervous system, stimulants accelerate it.The heart races.Blood pressure rises.Sleep disappears.Thoughts accelerate.Confidence grows.For a time, the world feels conquerable.But Holmes knows that every borrowed advantage eventually demands repayment.The chapter explores how stimulant use disorder develops through powerful reinforcement learning. Each episode of stimulant use floods the brain with dopamine, strengthening memories that connect pleasure with the drug, the environment, the people present, and even particular times of day. Gradually, everyday rewards lose their appeal while drug-associated cues become increasingly irresistible. Craving is no longer simply desire-it becomes conditioned biology.Holmes becomes fascinated by the distinction between positive and negative reinforcement.Initially, stimulants are taken because they produce euphoria, energy, confidence, and reward.Later, they are increasingly used simply to escape exhaustion, dysphoria, emotional emptiness, and overwhelming craving.The pursuit of pleasure quietly transforms into avoidance of suffering.As Holmes interviews those affected, another pattern emerges.Not everyone uses stimulants in the same way.Some binge for days before crashing.Others remain abstinent for weeks between episodes.Some use prescription medications appropriately throughout life without developing addiction.The disorder is defined not by the drug itself, but by the progressive loss of control despite mounting harm. DSM-5 therefore focuses on impaired control, craving, hazardous use, tolerance, withdrawal, and continued use despite significant consequences, with severity ranging from mild to severe depending upon the number of criteria met.The investigation then turns towards intoxication.Holmes watches an apparently confident businessman become increasingly suspicious.Every passing stranger appears threatening.Ordinary sounds become sinister.Minor coincidences seem like evidence of elaborate conspiracies.He learns that stimulant intoxication may progress from heightened confidence to severe paranoia, hallucinations, agitation, seizures, cardiac arrhythmias, hyperthermia, and even sudden death. Methamphetamine-induced psychosis may persist longer than cocaine-induced psychosis and sometimes becomes difficult to distinguish from primary schizophrenia, requiring careful longitudinal assessment.Eventually every binge ends.The crash arrives.Energy vanishes.Mood collapses.Sleep returns in overwhelming waves.Pleasure disappears.The chapter explains stimulant withdrawal as a state of profound dopamine depletion, characterised by fatigue, dysphoria, hypersomnia, increased appetite, vivid dreams, slowed thinking, and intense craving. Although rarely medically dangerous in itself, withdrawal may be accompanied by severe depression and suicidal thinking, making careful psychiatric assessment essential.Holmes also uncovers the extensive medical consequences hidden beneath the surface.Stimulants constrict blood vessels while increasing heart rate and blood pressure.The result may be myocardial infarction, stroke, cardiomyopathy, aortic dissection, seizures, cognitive impairment, and, particularly with methamphetamine, long-term neurotoxicity and increased risk of Parkinson disease. Repeated intranasal cocaine use damages nasal tissues, while chronic methamphetamine use produces the devastating dental destruction commonly known as “meth mouth.”The final lesson concerns treatment.Unlike alcohol or opioid withdrawal, stimulant withdrawal rarely requires complex medical detoxification.Instead, recovery depends upon rebuilding behaviour.Holmes finds that the strongest evidence supports psychological interventions rather than medication alone. Contingency management consistently produces the best outcomes by rewarding abstinence and treatment engagement. Cognitive behavioural therapy helps patients recognise triggers, manage cravings, and develop healthier coping strategies, while twelve-step programmes and community support provide long-term reinforcement for recovery. Although numerous medications have been studied, none has yet become an established first-line pharmacological treatment.As Holmes prepares to leave the sleepless city, dawn finally breaks.The streets grow quieter.For the first time, people begin to rest.He reflects that the greatest illusion stimulants create is not unlimited energy-it is the belief that human beings can permanently outrun the biological limits of the brain.Eventually, every borrowed hour must be repaid.Recovery begins not by running faster, but by learning once again how to stop.Key Takeaways* Stimulants include cocaine, amphetamines, methamphetamine, prescription stimulants, and synthetic cathinones.* They primarily act by increasing dopamine transmission within the brain’s reward pathways.* Stimulant use disorder is characterised by impaired control, craving, and continued use despite harm.* Intoxication may cause euphoria, insomnia, hypertension, agitation, paranoia, hallucinations, and cardiovascular emergencies.* Withdrawal typically produces fatigue, depression, hypersomnia, increased appetite, and intense craving.* Chronic stimulant use alters learning, memory, executive functioning, and reward processing.* Methamphetamine use is associated with neurotoxicity, cognitive impairment, and increased Parkinson disease risk.* Stimulant-induced psychosis may resemble primary psychotic disorders and requires careful longitudinal assessment.* Contingency management has the strongest evidence among psychosocial treatments, supported by CBT and mutual-help programmes.* No medication has yet become an established first-line treatment for stimulant use disorder. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe
• 
  PSYCH 078: Major Neurocognitive Disorders 01.08.2026 47นาที

  Imagine Medlock Holmes returning to the great library introduced in the previous chapter.At first glance, the library still stands.Its walls remain intact.The shelves are still filled with books.The familiar corridors continue to stretch into the distance.Yet something profound has changed.The librarians who once maintained the archives can no longer keep pace with the demands of the system.Catalogues become incomplete.Sections lose their organisation.Books are misplaced and never returned.Connections between different collections begin to disappear.The library represents the human brain.The gradual deterioration of its organisational systems represents a major neurocognitive disorder.This chapter explores a group of conditions characterised by significant decline in one or more cognitive domains severe enough to interfere with independence and everyday functioning.Unlike delirium, which develops rapidly and fluctuates, major neurocognitive disorders typically emerge insidiously. Their progression is often measured in months or years rather than hours or days.Holmes quickly discovers that memory is only one part of the story.Popular understanding often equates neurocognitive disorders with forgetfulness, but the reality is far more complex.Different individuals may experience impairments in attention, language, executive functioning, visuospatial abilities, social cognition, learning, reasoning, judgement, or behavioural regulation.The specific pattern depends on which neural systems are affected.As Holmes explores the library, he notices that some wings deteriorate more rapidly than others.One section struggles to create new memories.Another loses the ability to navigate familiar spaces.Elsewhere, language archives become difficult to access, while decision-making centres grow increasingly unreliable.The disorder is not defined by the loss of a single function.It is defined by a decline significant enough to affect daily life.The chapter examines how clinicians identify major neurocognitive disorders through careful history-taking, cognitive assessment, functional evaluation, collateral information, neuropsychological testing, and medical investigation.A central theme is the distinction between cognitive impairment and disability.Many individuals experience minor cognitive changes without losing independence.Major neurocognitive disorders are diagnosed when cognitive decline begins to impair essential activities such as managing finances, medications, transportation, communication, work responsibilities, or self-care.Holmes also discovers that these disorders arise from diverse causes.Neurodegenerative diseases.Cerebrovascular disease.Traumatic brain injury.Substance-related conditions.Infections.Metabolic disorders.Neurological illnesses.Although the pathways differ, they converge upon a common destination: progressive disruption of the cognitive systems that support everyday life.As the investigation continues, Holmes notices another important feature.The disorder affects not only cognition but identity.Families often describe subtle personality changes, altered emotional responses, shifts in social behaviour, or changes in decision-making long before severe cognitive deficits become apparent.The person remains present, yet the ways in which they engage with the world gradually change.The chapter also highlights the enormous impact on carers and families.Neurocognitive disorders rarely affect individuals alone.They alter relationships, roles, responsibilities, and future plans.The challenge therefore extends beyond diagnosis to include support, adaptation, planning, and compassionate care.Standing within the library’s central archive, Holmes observes some shelves dimming while others continue to glow brightly.Even amidst decline, many strengths remain.Procedural skills, emotional connections, creativity, humour, and personal values may persist long after other cognitive abilities have changed.The lesson becomes clear.Major neurocognitive disorders are not simply disorders of memory.They are disorders of complex brain systems that support independent living, relationships, and personal identity.The clinician’s task is not merely to identify decline, but to understand its pattern, determine its cause, and help individuals and families navigate the journey that follows.Key Takeaways* Major neurocognitive disorders involve significant decline in one or more cognitive domains.* Cognitive decline interferes with independence and daily functioning.* Memory impairment is common but not universally present.* Multiple domains may be affected, including attention, language, executive function, visuospatial abilities, and social cognition.* Major neurocognitive disorders usually develop gradually over time.* Diagnosis requires assessment of both cognition and functional abilities.* Numerous medical and neurological conditions can cause major neurocognitive disorders.* Collateral history from family members is often essential.* The disorders affect identity, relationships, and quality of life as well as cognition.* Management focuses on diagnosis, support, adaptation, safety, and maintaining quality of life. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe
• 
  PSYCH 077: Delirium 31.07.2026 58นาที

  Imagine Medlock Holmes arriving in a bustling city that normally functions with remarkable precision.Traffic flows smoothly.Messages are delivered accurately.Citizens recognise one another.Markets open on time.The entire system depends upon a continuous and reliable supply of energy.One morning, however, something changes.The city’s power grid begins to fluctuate.Lights flicker unpredictably.Communication systems fail intermittently.Road signs appear distorted.People become disoriented.Some wander aimlessly through the streets.Others become frightened and agitated.A few appear withdrawn and barely responsive.The city represents the brain.The failing power grid represents delirium.Unlike dementia, where the structure of the city gradually changes over time, delirium is a disorder of function.The machinery remains largely intact.The problem lies in the brain’s ability to maintain stable and coherent operation.As Holmes investigates, he notices one crucial clue.The disturbance developed rapidly.Only yesterday the city was functioning normally.Today it is profoundly altered.This sudden onset becomes one of the defining characteristics of delirium.Holmes soon discovers that attention is the first casualty.Citizens cannot focus on conversations.Instructions are forgotten moments after being given.Thoughts drift unpredictably.The city’s central communication network is no longer able to prioritise information.Without attention, every other cognitive process begins to falter.Memory becomes unreliable.Perception becomes distorted.Reasoning becomes fragmented.Awareness fluctuates from hour to hour.The city never fails in quite the same way twice.As he walks through different districts, Holmes observes that delirium presents in remarkably different forms.In one area, activity is frantic.People pace constantly.Voices are raised.Fear and agitation dominate.This is hyperactive delirium.Elsewhere, the city appears quiet.Citizens move slowly.Responses are delayed.People seem withdrawn and sleepy.This is hypoactive delirium.Holmes quickly realises that the quieter form is often more dangerous because it can easily be overlooked.A third district alternates unpredictably between the two states.Periods of agitation suddenly give way to profound lethargy.This is mixed delirium.The fluctuating nature of the syndrome becomes impossible to ignore.Holmes then turns his attention to the source of the failing power supply.He discovers that delirium is rarely a disease in itself.Rather, it is a warning signal.A manifestation of underlying physiological stress affecting the brain.Infections.Dehydration.Medication effects.Pain.Metabolic disturbances.Organ failure.Withdrawal states.Surgery.Hospitalisation.Almost any significant disruption to the body’s internal balance can destabilise the brain’s ability to maintain consciousness and attention.The brain, Holmes realises, is acting as an early warning system for systemic illness.The vulnerable city is particularly susceptible in older adults.In those with pre-existing dementia, the power grid is already operating with reduced reserves.Even minor disturbances can trigger widespread dysfunction.This explains why delirium and dementia frequently coexist.One does not exclude the other.Indeed, dementia is among the strongest risk factors for developing delirium.As Holmes investigates further, he discovers one of the most important lessons in medicine.Delirium is often reversible.If the underlying cause can be identified and treated, the city’s power can stabilise.Communication systems recover.Attention improves.Orientation returns.The citizens once again recognise the world around them.Yet when delirium is missed, consequences can be severe.Longer hospital stays.Functional decline.Falls.Institutionalisation.Increased mortality.The syndrome demands urgent recognition.The chapter concludes with Holmes standing before the city’s central power station.The lesson becomes clear.Delirium is not primarily a disorder of memory.It is a disorder of attention, awareness, and consciousness.A rapidly developing failure of the brain’s ability to maintain coherent functioning.The flickering lights of the city are not the problem themselves.They are signals pointing toward a deeper disturbance requiring immediate investigation.For the skilled clinician, recognising those signals may be the difference between recovery and catastrophe.Key Takeaways* Delirium is an acute disturbance of attention, awareness, and cognition.* Symptoms develop over hours to days and typically fluctuate throughout the day.* Impaired attention is the core clinical feature.* Delirium may present as hyperactive, hypoactive, or mixed subtypes.* It is usually caused by an underlying medical, neurological, toxic, or pharmacological condition.* Older adults and people with dementia are particularly vulnerable.* Delirium is a medical emergency that requires urgent assessment.* The condition is often reversible if the underlying cause is identified and treated.* Hypoactive delirium is common and frequently missed.* Delirium is associated with significant morbidity, mortality, and healthcare costs. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe
• 
  PSYCH 076: Cognitive Disorders: Introduction 31.07.2026 42นาที

  Imagine Medlock Holmes entering the largest library he has ever encountered.Endless shelves stretch beyond the horizon. Countless volumes contain memories, skills, language, relationships, emotions, and the accumulated experiences of an entire lifetime.At first glance, the library appears orderly and functional.Yet Holmes soon notices subtle signs that something is changing.A book returned to the wrong shelf.A catalogue entry that cannot be found.A corridor that once connected two sections now ends in confusion.A librarian searching for a familiar volume but unable to locate it.The library represents the human cognitive system.The missing books are not the problem.The problem lies within the systems responsible for organising, storing, accessing, and integrating information.As Holmes begins his investigation, he learns that cognitive disorders encompass a diverse group of conditions affecting memory, attention, language, executive functioning, perception, learning, and higher intellectual processes.Some disorders emerge suddenly following injury or illness.Others develop gradually over years.Some are reversible when underlying causes are identified and treated.Others represent progressive neurodegenerative processes that fundamentally alter how the brain functions.Moving through different sections of the library, Holmes discovers that cognition is not a single ability.Rather, it is a collection of interconnected systems working together.One section governs attention and concentration.Another manages learning and memory.Elsewhere, specialised archives contain language, visuospatial abilities, social understanding, and executive functions that support planning, judgement, and decision-making.When one area becomes disrupted, the effects often spread throughout the wider system.Holmes notices that families frequently recognise changes before clinicians do.A misplaced item.A forgotten appointment.Difficulty managing finances.Repeated questions.Changes in problem-solving.Trouble navigating familiar environments.These may seem minor in isolation, yet together they can signal significant alterations in cognitive functioning.As he explores further, Holmes encounters one of the central challenges in cognitive medicine.Normal ageing and pathological cognitive decline can sometimes appear similar.The task is not simply to identify that change has occurred, but to determine whether that change reflects expected ageing, a reversible medical condition, a psychiatric illness, or an evolving neurocognitive disorder.The chapter introduces the major categories of cognitive disorders and the conceptual frameworks used to understand them.Holmes examines how clinicians assess cognition, the importance of collateral information from family members, and the role of neuropsychological testing, neurological examination, laboratory investigations, and brain imaging.He also discovers that cognitive disorders are never merely disorders of memory.They affect identity, independence, relationships, occupation, and the ability to engage with the world.For patients and families alike, cognitive decline can reshape entire life narratives.As Holmes reaches the library’s central archive, he sees countless interconnected pathways linking memory, attention, language, emotion, and behaviour.The lesson becomes clear.Cognition is not a collection of isolated shelves.It is an integrated knowledge system whose health depends upon the coordinated functioning of the entire library.Understanding cognitive disorders begins with understanding how that library is organised—and what happens when its essential systems begin to fail.Key Takeaways* Cognitive disorders involve disturbances in one or more cognitive domains.* Cognition includes attention, memory, language, executive function, learning, perception, and social cognition.* Cognitive impairment may arise from neurological, psychiatric, medical, toxic, infectious, or degenerative causes.* Cognitive disorders vary from acute, reversible conditions to progressive neurodegenerative illnesses.* Normal ageing must be distinguished from pathological cognitive decline.* Assessment requires careful history-taking, cognitive examination, and collateral information.* Functional impairment is often a crucial indicator of clinically significant cognitive decline.* Neuropsychological testing can help characterise patterns of cognitive dysfunction.* Brain imaging and laboratory investigations are important components of assessment.* Cognitive disorders affect not only cognition but also independence, identity, relationships, and quality of life. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe